
HH Medical Diagnostics
Patent approvals and innovation in medical diagnosis.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
$1.6m | Series A | ||
Total Funding | 000k |
Beijing and Co Medical Diagnostic Technology, Inc. operates as a premier provider of specialized third-party medical testing services and clinical research support. The company leverages advanced mass spectrometry technology to offer precision measurements of serum vitamins, quantitative tests of amino acids, organic acids, and bioequivalency (BE) and pharmacodynamics (PK) studies. Serving a diverse clientele that includes hospitals, research institutions, and pharmaceutical companies, Beijing and Co is committed to scientific research and innovation. The company operates nationwide, ensuring high-level security and quality in its testing facilities. Its business model focuses on providing high-value diagnostic services and clinical support, generating revenue through service fees for its comprehensive testing projects. Keywords: mass spectrometry, clinical research, medical testing, serum vitamins, amino acids, organic acids, bioequivalency, pharmacodynamics, third-party services, innovation, scientific research.